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Molecular Mechanism of Rev/Rex-Dependent
1rans-Activation of Viral Genes
Yoshifumi Adachi
Rev of human immunodeficiency virus 1 (HIV-l) and Rex of human T-cell leukemia virus type I (HTLV-I)
are post-transcriptional trans-activator proteins of viral gene expression. Rev and Rex are localized in the
nucleolus and bind specifically to the Rev responsive element (RRE) and Rex responsive element (RxRE)
sequences in viral RNAs. Furthermore, the interactions of Rev/Rex proteins with cellular cofactors are
essential for Rev/Rex-dependent trans-activation in vivo. By means of affinity chromatography and
biospecific interaction analysis, we identified 38-kDa nucleolar shuttle protein B23 and 18-kDa proteins
(eukaryotic initiation factor 5A and prothymosin a) as the major proteins binding to the nucleolar
localization signal/RNA-binding domain and leucine-motif/activation domain of Rev/Rex, respectively.
Recently, nucleopolin-like proteins, Rab and Riplp were also identified as the Rev/Rex activation domain-
binding proteins. The functional relationship and molecular interaction between RevlRex, their binding
proteins, and RRElRxRE-containing viral RNAs are discussed.
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Rev of human immunodeficiency virus type 1
(HIV-1) and Rex of human T-cell leukemia virus type
I (HTLV-I) (1) are novel post-transcriptional trans-
activators. They are known to bind to their specific
targets on viral unspliced (gag-pol) and partially
spliced (env) mRNAs to enable the expression of viral
structural proteins by accumulating these mRNAs to
cytoplasm, hence they are critically required for viral
transcription followed by replication (1-6). Besides
having such a functional similarity, it has also been
reported that both proteins are phosphorylated and
are localized predominantely in the nucleolus when
they are expressed in eukaryotic cells (2). As shown
in Figure 1, they each possess two distinct functional
domains (4,6). One is nucleolar targeting signal
(NOS)/RNA-binding domain. The other is the leucine-
rich motif/activation domain.
The NOS/RNA-binding domain features a very
long basic amino-acid stretch which is capable of
forming an amphipathic a-helix structure. The
NOS/RNA-binding domain was shown to bind direct-
ly to the nucleolar protein B23 and the stem-bulge
structure in the Rev/Rex responsive element
(RRE/RxRE) of viral mRNAs (4). B23 has been shown
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HIV-1 Rev
1 MAGRSGDSDEDLLKAV 34 51
17 RLUFLYQSNPPPNPEG TRQARRNRRRRWRERQRQ IBSISERILSTYLGRSAEP 70
71 v LQLPPLERLTL NEDCG 90
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1 19












Figure 1. Molecular structure of HIV-l Rev, HTLV-I Rex,
and related proteins. The wavy underlines indicate a basic,
arginine-rich core which is essential for both the nucleolar
localization and sequence-specific binding to the RRE/RxRE
RNAs. The open boxes indicate a leucine-rich motif/activa-
tion domain which promotes the cytoplasmic transport of
RRE/RxRE RNAs by interaction with specific cofactors. The
circled P means in vivo phosphorylation site.
to migrate between the nucleolus and cytoplasm, act-
ing as a shuttle protein for the nucleocytoplasmic
transport of ribosomal components across the nuclear
membrane. Rev and Rex utilize this shuttle service to
be imported into the nucleolus as the Rev-B23 and
Rex-B23 complexes via the NOS/RNA-binding
domain. The RRE/RxRE RNAs having higher affini-
ties for Rev/Rex than B23 are interesting in view of in
vivo function of these interactions. Our findings sug-
gest that the nucleolar-imported complexes formed by
Rev/Rex and B23 are specifically dissociated by
RRE/RxRE RNAs. The Rev-RRE/Rex-RxRE complex-
es replaced via NOS/RNA-binding domain may then
be ready for the nuclear export machinery (Figure 2).
Mutational analysis has revealed that the leucine-
rich motif/activation domains are also important for
the complete functions of Rev/Rex (3). Interestingly,
peptide core motifs within these domains are func-
tionally interchangable between Rev and Rex (1-4).
These findings suggest that Rev and Rex should
require common cellular cofactors involved in the
cytoplasmic transport and/or accumulation of
RRE/RxRE RNAs, which should interact through the
activation domains. Recently, eukaryotic initiation
factor 5A (eIF-5A), proththymosin a (ProTa) (6),
nucleopolin-like proteins (Rab and Rip1p) were iden-
tified as the activation domain-binding proteins.
These proteins are capable of binding to the activa-
tion domain when Rev and Rex assembled onto
RRE/RxRE RNAs via NOS/RNA-binding domain and
of significantly enhancing Rev/Rex-dependent trans-
Figure 2. Possible mechanism of Rev-dependent trans-acti-
vation ofHIV-l genes.
activation of viral genes. It seems possible that the
subsequent interaction of the Rev-RRE/Rex-RxRE
complexes with eIF-5A, ProTa, Rab or Rip1p via the
activation domain may induce the nuclear export of
the complexes across the nuclear pores followed by
the preferential accumulation and translation of
RRE/RxRE RNAs (Figure 2).
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